Novo Nordisk

SEP 9, 2026 · PHASE 3 TRIAL

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

ClinicalTrials.gov

This is a Phase 3 registry record with no reported results; the study is active but not recruiting, so outcomes remain unreported in this source.

SEP 9, 2026 · PHASE 1 TRIAL

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

ClinicalTrials.gov

Phase 1 safety study with no posted results; registry record describes planned conduct only, not outcomes.

SEP 9, 2026 · PHASE 3 TRIAL

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcomes have not yet been reported.

SEP 4, 2026 · PHASE 3 TRIAL

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and outcome data are not yet available, making it an early-stage report of a planned intervention.

AUG 19, 2026 · PHASE 3 TRIAL

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

ClinicalTrials.gov

This is a clinical trial registry record describing a planned Phase 3 study with no results reported; the trial is actively recruiting and no efficacy or safety data are available.

AUG 19, 2026 · PHASE 1 TRIAL

A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity

ClinicalTrials.gov

This is a Phase 1 safety and pharmacokinetic study registration with no results posted; it describes planned enrollment and primary outcome measures only.

AUG 18, 2026 · PHASE 1 TRIAL

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

ClinicalTrials.gov

Phase 1 safety and tolerability study in a planned enrollment of 36 participants; no results are yet reported in this registry record.

AUG 18, 2026 · PHASE 3 TRIAL

A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

ClinicalTrials.gov

Phase 3 trial with completed recruitment (n=23) examining surrogate immune endpoints in Alzheimer's disease; no results posted in this registry record.